Antituberculosis drug-induced hepatotoxicity in children
Recent increases in the dosages of the essential antituberculosis agents isoniazid (INH), rifampicin and pyrazinamide for use in children recommended by World Health Organization have raised concerns regarding the risk of hepatotoxicity. Published data relating to the incidence and pathogenesis of a...
Saved in:
Main Author: | Peter R. Donald (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2011-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incidence and characteristics of antituberculosis drug-induced hepatotoxicity in children: a preliminary study
by: Bina Akura, et al.
Published: (2009) -
Prevalence of Hepatotoxicity From Antituberculosis Therapy
by: Arunava Saha, et al.
Published: (2016) -
Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis Hepatotoxicidade das drogas antituberculose entre pacientes coinfectados HIV/tuberculose
by: Maria de Fátima Silva de Lima, et al.
Published: (2012) -
Study of the pharmacokinetics of antituberculosis drug Biomairin
by: Sh. A. Shomurotov, et al.
Published: (2018) -
Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury
by: Quanxian Liu, et al.
Published: (2024)